Source: Institutional Research Information System (IRIS)
Vannini I.; Urbini M.; Melloni M.; Rossi T.; Gallerani G.; Palleschi M.; Azzali I.; Puccetti M.; Martinelli G.; Fabbri F., Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient, «FRONTIERS IN MEDICINE», 2022, 9, pp. 827206 - 827213 [Scientific article] Open Access
Durante G.; Broseghini E.; Comito F.; Naddeo M.; Milani M.; Salamon I.; Campione E.; Dika E.; Ferracin M., Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer, «EXPERT REVIEW OF MOLECULAR DIAGNOSTICS», 2022, 22, pp. 305 - 318 [Scientific article]
Mazzeschi, Martina; Sgarzi, Michela; Romaniello, Donatella; Gelfo, Valerio; Cavallo, Carola; Ambrosi, Francesca; Morselli, Alessandra; Miano, Carmen; Laprovitera, Noemi; Girone, Cinzia; Ferracin, Manuela; Santi, Spartaco; Rihawi, Karim; Ardizzoni, Andrea; Fiorentino, Michelangelo; D'Uva, Gabriele; Győrffy, Balázs; Palmer, Ruth; Lauriola, Mattia, The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2022, 41, pp. 113 - 131 [Scientific article] Open Access
Manuela Ferracin, Elisabetta Broseghini, Emi Dika, Pathophysiology roles and translational opportunities of miRNAs in cutaneous melanoma, in: MicroRNA in Human Malignancies, London, Elsevier Academic Press, 2022, pp. 339 - 384 [Chapter or essay]
Miglietta, Stefano; Girolimetti, Giulia; Marchio, Lorena; Sollazzo, Manuela; Laprovitera, Noemi; Coluccelli, Sara; De Biase, Dario; De Leo, Antonio; Santini, Donatella; Kurelac, Ivana; Iommarini, Luisa; Ghelli, Anna; Campana, Davide; Ferracin, Manuela; Perrone, Anna Myriam; Gasparre, Giuseppe; Porcelli, Anna Maria, MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer, «NON-CODING RNA», 2022, 8, pp. 1 - 13 [Scientific article] Open Access
Durante, Giorgio; Veronesi, Giulia; Misciali, Cosimo; Riefolo, Mattia; Lambertini, Martina; Tartari, Federico; Ricci, Costantino; Ferracin, Manuela; Dika, Emi, Dysplastic nevi and melanoma: microRNAs tell a divergent story, «PATHOLOGY, RESEARCH AND PRACTICE», 2022, 235, pp. 153942 - 153942 [Scientific article]
Lombardi, Giulia; Latorre, Roberta Valeria; Mosca, Alessandro; Calvanese, Diego; Tomasello, Luisa; Boni, Christian; Ferracin, Manuela; Negrini, Massimo; Dewik, Nader Al; Yassin, Mohamed; Ismail, Mohamed A; Carpentieri, Bruno; Sorio, Claudio; Lecca, Paola, Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 1 - 26 [Scientific article] Open Access
Calvo-Lozano, Olalla; García-Aparicio, Pablo; Raduly, Lajos-Zsolt; Estévez, Maria Carmen; Berindan-Neagoe, Ioana; Ferracin, Manuela; Lechuga, Laura M, One-Step and Real-Time Detection of microRNA-21 in Human Samples for Lung Cancer Biosensing Diagnosis, «ANALYTICAL CHEMISTRY», 2022, 94, pp. 14659 - 14665 [Scientific article] Open Access
De Matteis, Serena; Casadei, Beatrice; Lolli, Ginevra; Dicataldo, Michele; Barbato, Francesco; Dan, Elisa; Paccagnella, Andrea; Sinigaglia, Barbara; Bertuzzi, Clara; Arcari, Annalisa; Zazzeroni, Luca; Bernuzzi, Patrizia; Laprovitera, Noemi; Storci, Gianluca; Bertuccio, Salvatore Nicola; Ferracin, Manuela; Bonafe, Massimiliano; Zinzani, Pier Luigi; Bonifazi, Francesca, Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy, «FRONTIERS IN IMMUNOLOGY», 2022, 13, pp. 1 - 5 [Scientific article] Open Access
Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna, ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 2216 - 2229 [Scientific article] Open Access